Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 8,221–8,280 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

University of California, Santa Cruz1 University of California-Irvine Machine Learning Repository1 University of Cape Town Knowledge Translation Unit1 University of Ceylon Colombo medical school1 University of Chicago Institutional Review Board1 University of Chicago Medicine1 University of Chile1 University of Cincinnati Cancer Center1 University of Colorado Human Immune Monitoring Shared Resource Facility1 University of Colorado School of Medicine1 University of Cordoba1 University of Debrecen1 University of Dhaka Institute of Health Economics1 University of Durham1 University of East Anglia1 University of Exeter Medical School1 University of Exeter Public Health and Sport Sciences1 University of Florence1 University of Florida College of Dentistry1 University of Florida College of Medicine1 University of Florida Institutional Animal Care and Use Committee1 University of Florida, Gainesville1 University of Giessen1 University of Glasgow School of Medical and Life Sciences Ethics Committee1 University of Gondar Comprehensive Specialized Hospital Tertiary Eye Care and Training Center1 University of Gondar, Comprehensive and Specialized Hospital1 University of Gothenburg1 University of Gothenburg, Sweden1 University of Groningen1 University of Health Sciences Research and Training Hospital1 University of Houston Institutional Review Board1 University of Huddersfield1 University of Hull1 University of Illinois1 University of Illinois Hospital in Chicago1 University of Illinois at Urbana-Champaign1 University of Indonesia–Cipto Mangunkusumo Hospital1 University of Iowa Holden Comprehensive Cancer Center1 University of Jyväskylä1 University of Kansas Medical Centre1 University of Karachi1 University of Kent1 University of Kentucky1 University of Kisangani1 University of KwaZulu-Natal Biomedical Research EC1 University of Kwazulu-Natal1 University of Lahore1 University of Lancashire1 University of Latvia Statistics Laboratory1 University of Lausanne1 University of Limerick Education and Health Sciences Research Ethics Committee1 University of Limoges1 University of Liverpool1 University of London1 University of Manchester Research Ethics Committee1 University of Maryland Medical Center1 University of Maryland, Baltimore1 University of Miami Institutional Review Board1 University of Michigan Medical Institutional Review Board1 University of Michigan Medical School1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 310 of 946

376 Harnessing sentinel lymph nodes for adoptive cell therapy in head and neck squamous cell carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

93.4%

University of California San Diego Gleiberman Head and Neck Cancer Center Head and neck squamous cell carcinoma (HNSCC)tdRT_SLN tdRT Adoptive cell therapy HNSCC

… Institutional Animal Care and Use Committee of UCSD (#S16200), University of California San Diego. The study was conducted in accordance with the local legislati…

379 Selection of CD103+CD31-CD8+ cells enriches tumor reactivity of tumor infiltrating lymphocytes (TIL) independent of personalized sequencing

jitc · abstract · 2025-11-04 · 2 matching annotations

87.0%

National Institutes of Health NIH IL-2 melanomas epithelial cancers gastrointestinal cancers

…;370(6522):1328-1334.Ethics Approval This study was approved by National Institutes of Health (NIH) Internal Review Board (IRB); approval number NCT00068003.…

382 Improved ex vivo expansion of tumour-infiltrating lymphocytes from gynaecological cancer biopsies using dendritic cells derived from the leukemic cell line DCOne

jitc · abstract · 2025-11-04 · 2 matching annotations

84.7%

UMCG N. Engl. J. Med.metastatic melanoma ipilimumab IL-2 IL-2-based solid tumours endometrial cancer metastatic ovarian cancer Adoptive cell therapy+1 more

…iative has been approved by the medical ethics committee of the UMCG (no. 2010/109) and has been ISO certified (9001:2008 Healthcare…

396 Decoding and targeting the CMML antigenic landscape with novel, highly effective multi-epitope specific cytotoxic CD4+ T cells

jitc · abstract · 2025-11-04 · 2 matching annotations

85.3%

NCT02775383 National MDS Natural History Study biobank chronic myelomonocytic leukemia (CMML)hypomethylating agents Adoptive T-cell therapy allogeneic stem cell transplantation

…ofiling on bone marrow cells from CMML/MDS MPN patient cohort ( NCT02775383) obtained from the National MDS Natural History Study biobank a…

40 Blood-based proteomic and glycoproteomic biomarkers exhibit promising additivity in predicting response in checkpoint inhibitor treated lung cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

94.4%

Translational Immunology Laboratory University of Sydney Pembrolizumab lung cancer Durvalumab Nivolumab The University of Sydney Ethics Board

…and n=29 ICI+chemo). Pre-treatment samples were provided by the Translational Immunology Laboratory at the University of Sydney. The cohort consisted of 21 males a…

420 Immune checkpoint blockade of PSGL-1 overcomes resistance to anti-PD-1 treatment in melanoma by enhancing effector T cell differentiation

jitc · abstract · 2025-11-04 · 2 matching annotations

92.1%

Sanford Burnham Prebys PSGL-1 melanoma tumors The NIH Shared Instrumentation Grant S10OD032325 PSGL1

…32325 for the Cytek Aurora housed in the Flow Cytometry Core at Sanford Burnham Prebys.References 1.Hope JL, Otero DC, Bae EA, Stairiker CJ, Palete AB…

430 Clonal diversification reshapes the exhaustion landscape of tumor-infiltrating T cells following immunotherapy

jitc · abstract · 2025-11-04 · 2 matching annotations

81.2%

mouse tumor model AbbVie ICI colorectal tumors anti-CD40 agonist antibody human cancer types T cell exhaustion

…we performed a longitudinal analysis using serial biopsies from mouse tumor model treated with ICI and exhibiting differential responses, integra…

434 Efficacy and prognostic model development of immune checkpoint inhibitor rechallenge in recurrent or metastatic nasopharyngeal carcinoma: a real-world study

jitc · abstract · 2025-11-04 · 2 matching annotations

90.3%

The First Affiliated Hospital of Nanchang University Sun Yat-sen University Cancer Center Institutional Review Board locoregional therapy ICI rechallenge recurrent or metastatic nasopharyngeal carcinoma (RM-NPC)

…his study is supported by Clinical Research Training Project of The First Affiliated Hospital of Nanchang University (No. YFYLCYJPY202444) and Science and Technology Project of Hea…

436 Immune checkpoint inhibitors in sinonasal squamous cell carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

96.0%

USC Norris Comprehensive Cancer Center Los Angeles General Medical Center pembrolizumab cetuximab Sinonasal malignancies squamous cell carcinoma SNSCC

…rapy for histologically confirmed recurrent/metastatic SNSCC at USC Norris Comprehensive Cancer Center and Los Angeles General Medical Center (LAGMC) from 2016 to 202…

441 Reimagining bladder cancer immunotherapy: local non-viral gene delivery of DNA-encoded immune checkpoint inhibitors

jitc · abstract · 2025-11-04 · 2 matching annotations

80.4%

C57BL/6 mice nivolumab pembrolizumab detalimogene voraplasmid DDX

…duration, dose response, and systemic exposure were assessed in C57BL/6 mice after IVI. A custom paratope-specific immunoassay on the Meso S…

448 The brain tissue environment contributes to a unique response of glioblastoma against immunotherapy

jitc · abstract · 2025-11-04 · 2 matching annotations

78.7%

National Cancer Institute Eur J Clin Invest NOX-A12 Glioblastoma GBM ICB immunotherapy ICB

… animal experiments and protocols were reviewed and approved by National Cancer Institute…

449 SUSD2 augments antitumor immunity by targeting TRAF2/NF-κB/CXCL1 axis in lung adenocarcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

90.7%

TCGA-LUAD TCGA lung adenocarcinoma SUSD2 Immune checkpoint blockades syngeneic tumors

…th the overall survival of patients with lung adenocarcinoma in TCGA-LUAD (figure 1C-D). Knockdown of SUSD2 significantly promoted tumor …